• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清尿酸水平与无症状个体亚临床冠状动脉粥样硬化:一项观察性队列研究。

Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: An observational cohort study.

机构信息

Department of Rheumatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

Department of Thoracic and Cardiovascular Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

出版信息

Atherosclerosis. 2019 Sep;288:112-117. doi: 10.1016/j.atherosclerosis.2019.07.017. Epub 2019 Jul 19.

DOI:10.1016/j.atherosclerosis.2019.07.017
PMID:31352272
Abstract

BACKGROUND AND AIMS

There are limited data on the association between serum uric acid (SUA) level and subclinical coronary atherosclerosis. This study investigated the influence of SUA level on subclinical coronary atherosclerosis, as detected by coronary computed tomography angiography (CCTA), in an asymptomatic population.

METHODS

We evaluated 6431 asymptomatic individuals (mean age 53.6 ± 7.6 years, 4691 men [72.9%]) with no prior history of coronary artery disease, who voluntarily underwent laboratory tests and CCTA as part of a general health examination. The participants were stratified into quartiles according to their SUA levels. Coronary atherosclerotic plaques (calcified, mixed, and non-calcified plaques) were assessed using CCTA. Logistic regression analysis was used to determine the association between SUA levels and subclinical coronary atherosclerosis.

RESULTS

The prevalence of any atherosclerotic, calcified, mixed, and non-calcified plaques increased with SUA quartiles (all p < 0.001). After adjustment for cardiovascular risk factors, there were no statistically significant differences in the adjusted odds ratios for calcified plaque (1.19; 95% CI 0.98-1.46; p = 0.080) and mixed plaque (1.25; 95% CI 0.94-1.67; p = 0.132) in the fourth SUA quartile compared to the first quartile. However, the adjusted odds ratios for any atherosclerotic plaque (1.39; 95% CI 1.16-1.68; p < 0.001) and non-calcified plaque (1.38; 95% CI 1.11-1.72; p = 0.004) were significantly higher in the fourth SUA quartile.

CONCLUSIONS

In asymptomatic individuals, high SUA level was an independent predictor of non-calcified plaques, suggesting an increased cardiovascular risk.

摘要

背景和目的

血清尿酸(SUA)水平与亚临床冠状动脉粥样硬化之间的关联数据有限。本研究旨在调查无症状人群中 SUA 水平对冠状动脉计算机断层扫描血管造影(CCTA)检测到的亚临床冠状动脉粥样硬化的影响。

方法

我们评估了 6431 名无症状个体(平均年龄 53.6±7.6 岁,4691 名男性[72.9%]),他们没有先前的冠状动脉疾病史,自愿接受实验室检查和 CCTA 作为一般健康检查的一部分。参与者根据 SUA 水平分为四组。使用 CCTA 评估冠状动脉粥样硬化斑块(钙化、混合和非钙化斑块)。使用逻辑回归分析确定 SUA 水平与亚临床冠状动脉粥样硬化之间的关联。

结果

任何粥样硬化、钙化、混合和非钙化斑块的患病率随 SUA 四分位升高而增加(均 p<0.001)。在校正心血管危险因素后,第四 SUA 四分位与第一四分位相比,钙化斑块(1.19;95%CI 0.98-1.46;p=0.080)和混合斑块(1.25;95%CI 0.94-1.67;p=0.132)的校正比值比无统计学差异。然而,第四 SUA 四分位与第一四分位相比,任何粥样硬化斑块(1.39;95%CI 1.16-1.68;p<0.001)和非钙化斑块(1.38;95%CI 1.11-1.72;p=0.004)的校正比值比显著更高。

结论

在无症状个体中,高 SUA 水平是无钙化斑块的独立预测因子,提示心血管风险增加。

相似文献

1
Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: An observational cohort study.血清尿酸水平与无症状个体亚临床冠状动脉粥样硬化:一项观察性队列研究。
Atherosclerosis. 2019 Sep;288:112-117. doi: 10.1016/j.atherosclerosis.2019.07.017. Epub 2019 Jul 19.
2
Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.非酒精性脂肪性肝病与亚临床冠状动脉粥样硬化的相关性:一项观察性队列研究。
J Hepatol. 2018 May;68(5):1018-1024. doi: 10.1016/j.jhep.2017.12.012. Epub 2017 Dec 20.
3
Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.脂蛋白(a)与无症状个体亚临床冠状动脉粥样硬化。
Atherosclerosis. 2022 May;349:190-195. doi: 10.1016/j.atherosclerosis.2021.09.027. Epub 2021 Sep 28.
4
Association between serum phosphorus and subclinical coronary atherosclerosis in asymptomatic Korean individuals without kidney dysfunction.血清磷与无症状肾功能正常的韩国人群亚临床冠状动脉粥样硬化的关系。
Am J Clin Nutr. 2020 Jul 1;112(1):66-73. doi: 10.1093/ajcn/nqaa091.
5
Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals.同型半胱氨酸不是无症状个体亚临床冠状动脉粥样硬化的危险因素。
PLoS One. 2020 Apr 8;15(4):e0231428. doi: 10.1371/journal.pone.0231428. eCollection 2020.
6
Serum Uric Acid Is Independently Associated with Coronary Calcification in an Asymptomatic Population.血清尿酸与无症状人群的冠状动脉钙化独立相关。
J Cardiovasc Transl Res. 2019 Jun;12(3):204-210. doi: 10.1007/s12265-018-9843-8. Epub 2018 Nov 9.
7
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study.性别对尿酸水平的影响及其与冠状动脉疾病程度的关系:一项单中心研究。
Atherosclerosis. 2015 Jul;241(1):241-8. doi: 10.1016/j.atherosclerosis.2015.03.030. Epub 2015 Mar 20.
8
Frequency and Significance of Right Bundle Branch Block and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals.无症状个体中右束支传导阻滞与亚临床冠状动脉粥样硬化的频率及意义。
Am J Cardiol. 2021 Nov 1;158:30-36. doi: 10.1016/j.amjcard.2021.07.042. Epub 2021 Aug 27.
9
The association between serum uric acid and asymptomatic intracranial arterial stenosis in middle-aged Koreans.韩国中年人群血清尿酸与无症状颅内动脉狭窄之间的关联。
Nutr Metab Cardiovasc Dis. 2018 Jan;28(1):14-22. doi: 10.1016/j.numecd.2017.10.019. Epub 2017 Oct 27.
10
Variation in atherosclerotic plaque composition according to increasing coronary artery calcium scores on computed tomography angiography.根据 CT 血管造影检查中冠状动脉钙评分的增加,动脉粥样硬化斑块成分的变化。
Int J Cardiovasc Imaging. 2010 Dec;26(8):923-32. doi: 10.1007/s10554-010-9625-0. Epub 2010 Apr 29.

引用本文的文献

1
A Systematic Review of Oxidative Stress Markers and Risk of Coronary Artery Calcification.氧化应激标志物与冠状动脉钙化风险的系统评价
J Tehran Heart Cent. 2024 Oct;19(4):230-242. doi: 10.18502/jthc.v19i4.17606.
2
Correlations of serum uric acid, fibrinogen and homocysteine levels with carotid atherosclerosis in hypertensive patients.高血压患者血清尿酸、纤维蛋白原及同型半胱氨酸水平与颈动脉粥样硬化的相关性
Front Cardiovasc Med. 2025 Mar 3;12:1433107. doi: 10.3389/fcvm.2025.1433107. eCollection 2025.
3
Sex difference in the risk of coronary artery calcification progression related to hyperuricemia among asymptomatic 12,316 Korean adults.
在 12316 名无症状韩国成年人中,高尿酸血症与冠状动脉钙化进展风险的性别差异。
Sci Rep. 2024 Nov 20;14(1):28710. doi: 10.1038/s41598-024-80324-2.
4
Serum Uric Acid and Hyperuricemia Associate with Coronary Artery Disease among Postmenopausal Women.绝经后女性血清尿酸及高尿酸血症与冠状动脉疾病相关。
Rev Cardiovasc Med. 2022 Jun 24;23(7):222. doi: 10.31083/j.rcm2307222. eCollection 2022 Jul.
5
Role of legumain in metabolic dysfunction, diagnosis, and prognosis of patients with atherosclerosis.瓜氨酸酶在动脉粥样硬化患者代谢功能障碍、诊断和预后中的作用。
Medicine (Baltimore). 2024 Jul 19;103(29):e38896. doi: 10.1097/MD.0000000000038896.
6
The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor.冠状动脉疾病与高尿酸血症的潜在关系:一种心脏代谢危险因素。
Heliyon. 2023 May 9;9(5):e16097. doi: 10.1016/j.heliyon.2023.e16097. eCollection 2023 May.
7
Association Between Serum Uric Acid Level and Carotid Atherosclerosis and Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.血清尿酸水平与 2 型糖尿病患者颈动脉粥样硬化及代谢综合征的关系。
Front Endocrinol (Lausanne). 2022 Jun 13;13:890305. doi: 10.3389/fendo.2022.890305. eCollection 2022.
8
Association between serum urate level and carotid atherosclerosis: an insight from a post hoc analysis of the PRIZE randomised clinical trial.血清尿酸水平与颈动脉粥样硬化的关系:PRIZE 随机临床试验事后分析的新发现。
RMD Open. 2022 Apr;8(1). doi: 10.1136/rmdopen-2022-002226.
9
CTRP3 protects against uric acid-induced endothelial injury by inhibiting inflammation and oxidase stress in rats.CTRP3 通过抑制大鼠炎症和氧化应激来防止尿酸诱导的内皮损伤。
Exp Biol Med (Maywood). 2022 Jan;247(2):174-183. doi: 10.1177/15353702211047183. Epub 2021 Oct 4.
10
Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.硫酸镁改善患有一或两支冠状动脉疾病患者的一些动脉粥样硬化危险因素:一项双盲临床试验研究。
Clin Pharmacol. 2020 Sep 25;12:159-169. doi: 10.2147/CPAA.S261264. eCollection 2020.